Home / Inspections / 1306258

FDA Inspection 1306258 — Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated — FEI 1000513211

The FDA completed an inspection of Vertex Pharmaceuticals Incorporated on March 3, 2026 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 3, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Facility

Other inspections at this facility

  • 1246447 (NAI Thu Aug 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1205834 (VAI Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1180001 (NAI Fri Aug 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1029564 (NAI Thu Oct 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988733 (VAI Wed Sep 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources